RMD · Resmed Inc · Webcasts, Transcripts & Audio
$223.14
+1.99 (+0.90%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$32.02B
Shares
144.25M
Volume · Oct 2
101.06K
Avg daily vol (3M)
1.41M
Resmed Inc Webcasts
Earnings calls, investor updates, investor days and conferences for Resmed Inc (RMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲15.5%
$1.03B
$224.91M
'23 Q2
23-01-26
▲29.2%
$1.12B
$232.50M
'23 Q3
23-04-27
▲22.7%
$1.12B
$229.66M
'23 Q4
23-08-03
▲16%
$1.10B
$219.42M
'24 Q1
23-10-26
▲12.5%
$1.16B
$208.80M
'24 Q2
24-01-24
▲7.2%
$1.20B
$300.49M
'24 Q3
24-04-25
▲9%
$1.22B
$292.24M
'24 Q4
24-08-01
▲11.1%
$1.22B
$311.36M
'25 Q1
24-10-24
▲10.3%
$1.28B
$344.62M
'25 Q2
25-01-30
▲7.9%
$1.29B
$365.04M
'25 Q3
25-04-23
▲10.2%
$1.35B
$379.70M
'25 Q4
25-07-31
▲9.1%
$1.34B
$348.54M
'26 Q1
25-10-30
▲11%
$1.42B
$392.59M
'26 Q2
26-01-29
▲10.8%
$1.43B
$398.73M
'26 Q3
26-04-30
LATEST
▲8.6%
$1.46B
$383.43M
'26 Q4
26-08-06
Annual General Meeting
Investor event
2026-11-18
Resmed Inc (RMD) November 2026 Annual General Meeting
Scheduled
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY27 · Q1
2026-10-29
Resmed Inc (RMD) Q1 2027 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Capital Markets Day
Investor event
2026-09-21
Resmed Inc (RMD) September 2026 Capital Markets Day
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-09-15
Resmed Inc (RMD) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q4
2026-08-06
Resmed Inc (RMD) Q4 2026 Earnings Call Transcript
Confident tone
Device Platform Innovation
GLP-1 Medications as Tailwind
Revenue and Earnings Growth
Revenue
$1.46B*
▲ 8.6% YoY Gross margin
58.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Investor Update
Investor event
2026-08-06
Resmed Inc (RMD) August 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
Resmed Inc (RMD) June 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
Resmed Inc (RMD) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Investor Update
Investor event
2026-04-30
Resmed Inc (RMD) April 2026 Investor Update
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-04-30
Resmed Inc (RMD) Q3 2026 Earnings Call Transcript
Confident tone
Sleep apnea clinical evidence and CME
GLP-1 / Eli Lilly combination therapy opportunity
Leadership transition (CFO)
Revenue
$1.43B
▲ 10.8% YoY Diluted EPS
$2.74
▲ 10.5% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-01-29
Resmed Inc (RMD) Q2 2026 Earnings Call Transcript
Confident tone
GLP-1 drugs as a tailwind
Mask portfolio expansion and reacceleration
Residential Care Software (RCS) portfolio management
Revenue
$1.42B
▲ 11% YoY Diluted EPS
$2.68
▲ 14.5% YoY Gross margin
61.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-01-12
Resmed Inc (RMD) January 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-01-12
Resmed Inc (RMD) January 2026 Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2025-10-30
Resmed Inc (RMD) Q1 2026 Earnings Call Transcript
Confident tone
Market penetration and patient awareness
Residential Care Software (RCS) business
Revenue growth across regions
Revenue
$1.34B
▲ 9.1% YoY Diluted EPS
$2.37
▲ 12.3% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-07-31
Resmed Inc (RMD) Q4 2025 Earnings Call Transcript
Confident tone
GLP-1 and patient demand generation
Acquisitions and inorganic growth
Revenue and earnings growth
Revenue
$1.35B*
▲ 10.2% YoY Gross margin
60.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-04-23
Resmed Inc (RMD) Q3 2025 Earnings Call Transcript
Confident tone
Sleep apnea patient funnel
US manufacturing and R&D footprint
Tariffs and trade policy
Revenue
$1.29B
▲ 7.9% YoY Diluted EPS
$2.48
▲ 21.6% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-01-30
Resmed Inc (RMD) Q2 2025 Earnings Call Transcript
Confident tone
Consumer tech / medtech convergence (Apple, Samsung, CES)
GLP-1 drugs and sleep apnea awareness
Gross margin expansion
Revenue
$1.28B
▲ 10.3% YoY Diluted EPS
$2.34
▲ 64.8% YoY Gross margin
58.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-10-24
Resmed Inc (RMD) Q1 2025 Earnings Call Transcript
Confident tone
AirSense Platform / Device Sales
Consumer Wearables / Sleep Apnea Awareness
Digital Health Ecosystem
Revenue
$1.22B
▲ 11.1% YoY Diluted EPS
$2.11
▲ 41.6% YoY Gross margin
58.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-08-01
Resmed Inc (RMD) Q4 2024 Earnings Call Transcript
Confident tone
Geographic expansion and global reach
GLP-1 / pharma megatrend
Masks and accessories business
Revenue
$1.22B*
▲ 9% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-04-25
Resmed Inc (RMD) Q3 2024 Earnings Call Transcript
Confident tone
Device Growth and Product Portfolio
Inventory and Supply
Software-as-a-Service and Digital Health
Revenue
$1.20B
▲ 7.2% YoY Diluted EPS
$2.04
▲ 29.1% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-01-24
Resmed Inc (RMD) Q2 2024 Earnings Call Transcript
Confident tone
Core sleep and breathing health growth
Geographic growth and market dynamics
SaaS and digital health ecosystem
Revenue
$1.16B
▲ 12.5% YoY Diluted EPS
$1.42
▼ 7.2% YoY Gross margin
55.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-10-26
Resmed Inc (RMD) Q1 2024 Earnings Call Transcript
Revenue
$1.10B
▲ 16% YoY Diluted EPS
$1.49
▲ 4.2% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-08-03
Resmed Inc (RMD) Q4 2023 Earnings Call Transcript
Revenue
$1.12B*
▲ 22.7% YoY Gross margin
55.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-04-27
Resmed Inc (RMD) Q3 2023 Earnings Call Transcript
Revenue
$1.12B
▲ 29.2% YoY Diluted EPS
$1.58
▲ 29.5% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-01-26
Resmed Inc (RMD) Q2 2023 Earnings Call Transcript
Revenue
$1.03B
▲ 15.5% YoY Diluted EPS
$1.53
▲ 11.7% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-10-27
Resmed Inc (RMD) Q1 2023 Earnings Call Transcript
Revenue
$950.29M
▲ 5.1% YoY Diluted EPS
$1.43
▲ 2.9% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-08-11
Resmed Inc (RMD) Q4 2022 Earnings Call Transcript
Revenue
$914.74M*
▲ 4.4% YoY Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-04-28
Resmed Inc (RMD) Q3 2022 Earnings Call Transcript
Revenue
$864.50M
▲ 12.5% YoY Diluted EPS
$1.22
Gross margin
56.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-01-27
Resmed Inc (RMD) Q2 2022 Earnings Call Transcript
Revenue
$894.87M
▲ 11.9% YoY Diluted EPS
$1.37
▲ 11.4% YoY Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-10-28
Resmed Inc (RMD) Q1 2022 Earnings Call Transcript
Revenue
$904.01M
▲ 20.2% YoY Diluted EPS
$1.39
▲ 13.9% YoY Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-08-05
Resmed Inc (RMD) Q4 2021 Earnings Call Transcript
Revenue
$876.10M*
▲ 13.7% YoY Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-04-29
Resmed Inc (RMD) Q3 2021 Earnings Call Transcript
Revenue
$768.77M
▼ 0.1% YoY Diluted EPS
$-0.54
▼ 148.2% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-01-28
Resmed Inc (RMD) Q2 2021 Earnings Call Transcript
Revenue
$800.01M
▲ 8.7% YoY Diluted EPS
$1.23
▲ 11.8% YoY Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-10-29
Resmed Inc (RMD) Q1 2021 Earnings Call Transcript
Revenue
$751.94M
▲ 10.4% YoY Diluted EPS
$1.22
▲ 47% YoY Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-08-05
Resmed Inc (RMD) Q4 2020 Earnings Call Transcript
Revenue
$770.35M*
▲ 9.3% YoY Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-04-30
Resmed Inc (RMD) Q3 2020 Earnings Call Transcript
Revenue
$769.46M
▲ 16.2% YoY Diluted EPS
$1.12
▲ 53.4% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-01-30
Resmed Inc (RMD) Q2 2020 Earnings Call Transcript
Revenue
$736.16M
▲ 13.1% YoY Diluted EPS
$1.10
▲ 27.9% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-09-30
Resmed Inc (RMD) Q1 2020 Earnings Call Transcript
Revenue
$681.06M
▲ 15.8% YoY Diluted EPS
$0.83
▲ 13.7% YoY Gross margin
57.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–38 of 38 webcasts
Key facts
CIK
943819
CUSIP
761152107
13F (30d)
26 filings
20 filers
Visit website
Investor relations